Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.

Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L, Myles JP, Warwick J.

Breast Cancer Res. 2005;7(6):258-65. Epub 2005 Nov 10.

2.

Effect of screening and adjuvant therapy on mortality from breast cancer.

Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators..

N Engl J Med. 2005 Oct 27;353(17):1784-92.

4.

Overdiagnosis and breast cancer screening.

Day NE.

Breast Cancer Res. 2005;7(5):228-9. Epub 2005 Aug 30. No abstract available.

5.

Some current issues in breast cancer screening.

Duffy SW.

J Med Screen. 2005;12(3):128-33.

PMID:
16156943
6.
7.

The influence of mammographic screening on national trends in breast cancer incidence.

Møller B, Weedon-Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M, Haldorsen T.

Eur J Cancer Prev. 2005 Apr;14(2):117-28.

PMID:
15785315
8.

Are there downsides to mammography screening?

Baines CJ.

Breast J. 2005 Mar-Apr;11 Suppl 1:S7-10. Review.

PMID:
15725116
9.
10.

Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?

Paci E, Warwick J, Falini P, Duffy SW.

J Med Screen. 2004;11(1):23-7.

PMID:
15006110
11.
12.

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.

Yen MF, Tabár L, Vitak B, Smith RA, Chen HH, Duffy SW.

Eur J Cancer. 2003 Aug;39(12):1746-54.

PMID:
12888370
13.

Breast cancer incidence after the start of mammography screening in Denmark.

Olsen AH, Jensen A, Njor SH, Villadsen E, Schwartz W, Vejborg I, Lynge E.

Br J Cancer. 2003 Feb 10;88(3):362-5.

14.

The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.

Duffy SW, Tabár L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A, Tholin M, Wiege M, Akerlund A, Wu HM, Tung TS, Chiu YH, Chiu CP, Huang CC, Smith RA, Rosén M, Stenbeck M, Holmberg L.

Cancer. 2002 Aug 1;95(3):458-69.

15.

Long-term effects of mammography screening: updated overview of the Swedish randomised trials.

Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE.

Lancet. 2002 Mar 16;359(9310):909-19. Review. Erratum in: Lancet 2002 Aug 31;360(9334):724.

PMID:
11918907
16.

Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.

Jonsson H, Nyström L, Törnberg S, Lenner P.

J Med Screen. 2001;8(3):152-60.

PMID:
11678556
17.

Nonattendance in mammographic screening: a study of intraurban differences in Malmö, Sweden, 1990-1994.

Matson S, Andersson I, Berglund G, Janzon L, Manjer J.

Cancer Detect Prev. 2001;25(2):132-7.

PMID:
11341348
18.

Breast cancer screening with mammography: overview of Swedish randomised trials.

Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, et al.

Lancet. 1993 Apr 17;341(8851):973-8. Erratum in: Lancet 1993 Nov 27;342(8883):1372.

PMID:
8096941
19.

Lead time in breast cancer detection and implications for periodicity of screening.

Shapiro S, Goldberg JD, Hutchison GB.

Am J Epidemiol. 1974 Nov;100(5):357-66. No abstract available.

PMID:
4417355
20.

Breast cancer: age-specific growth rates and screening strategies.

Moskowitz M.

Radiology. 1986 Oct;161(1):37-41.

PMID:
3532183

Supplemental Content

Support Center